type II interferon IFN-gamma response
Selected indexed studies
- IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade. (J Clin Invest, 2017) [PMID:28650338]
- Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion. (Front Immunol, 2018) [PMID:29780381]
- Broadening horizons: the role of ferroptosis in cancer. (Nat Rev Clin Oncol, 2021) [PMID:33514910]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Interferon-γ induces tumor resistance to anti-PD-1 immunotherapy by promoting YAP phase separation. (2021) pubmed
- Tissue-specific abundance of interferon-gamma drives regulatory T cells to restrain DC1-mediated priming of cytotoxic T cells against lung cancer. (2023) pubmed
- IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade. (2017) pubmed
- Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion. (2018) pubmed
- Broadening horizons: the role of ferroptosis in cancer. (2021) pubmed
- Polarizing Macrophages In Vitro. (2018) pubmed
- Antigen-specific B cell depletion for precision therapy of mucosal pemphigus vulgaris. (2020) pubmed
- Current prospects of type II interferon γ signaling and autoimmunity. (2017) pubmed
- Revealing hyperactivated IFN-γ pathways in perianal fistulizing Crohn's disease using single-cell and spatial multi-omics. (2025) pubmed
- Escape from IFN-γ-dependent immunosurveillance in tumorigenesis. (2017) pubmed